Jennifer Crombie, MD, Dana-Farber Cancer Institute, Boston, Massachusetts, discusses results from a real-world study of lisocabtagene maraleucel in patients with relapsed/refractory large B-cell lymphoma. Similar to published findings…
Tanya Siddiqi, MD, medical director of lymphoma, City of Hope, Orange County, California, discusses the primary analysis of the TRANSCEND CLL 004 trial. This phase 1/2, single-arm, multicenter…
The frameless Deep Brain Stimulation technique was first used by Zachary T. Levine, MD, FAANS, Director of Neurosciences for Holy Cross Health, and consists of an implant that…
Approximately one-third of patients with Huntington’s disease (HD) experience depression. In 21 published case reports where electroconvulsive therapy (ECT) was used to treat depression in patients with HD,…
Although there exists no reliable government database about demand for cadavers, sources like National Geographic and The Economist have reported on data compiled from individual agencies about shortages…
“It’s a time of tremendous revolution in Parkinson’s disease,” says Un J. Kang, MD, H. Houston Merritt Professor of Neurology and Chief of the Division of Movement Disorders…
